Many Americans unaware of increased risk to UV exposure for certain drugs, light-colored eyes
May 23rd 2014The American Academy of Ophthalmology recently released results of a poll that found the majority of Americans are unaware of the increased risks to ultraviolet (UV) light exposure that are linked to common drugs and having light-colored eyes.
Eleven Biotherapeutics presents data on protein therapeutics for anterior, posterior eye diseases
May 15th 2014During the Association for Research in Vision and Ophthalmology meeting last week, Eleven Biotherapeutics presented data for 2 of its protein therapeutics, which demonstrate the role of cytokine biology to target both anterior and posterior eye diseases.
Study: Wearers of 1-Day Acuvue Moist report low incidence of ocular adverse events
May 12th 2014A year-long study of 1-Day Acuvue TruEye and 1-Day Acuvue Moist brands designed to observe “real-life” contact lens wear found that subjects who wore 1-Day Acuvue Moist reported low incidence of adverse events.
B+L report finds resistance of some ocular pathogens has increased in U.S.
May 12th 2014During the ARVO meeting last week, Bausch + Lomb researchers presented results from the 5th Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study in the United States, as well as the first data from the study in Canada.
Second Sight, Kellogg Eye Center finding early success with artificial retina
May 9th 2014Second Sight Medical Products, Inc. and the University of Michigan Kellogg Eye Center experienced recent success with an artificial retina, which is gaining national attention and giving patients back their sight.
OneSight, SUNY to open vision centers at NYC public schools through Project NYSee
May 6th 2014New York City’s United Federation of Teachers (UFT) and OneSight, a global vision care nonprofit, announce Project NYSee, a new partnership providing New York City public school students with access to vision care.